- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 65.18M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $59K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $165.01M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $114.09M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $13.39M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $14.65M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $354.51M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $205.35M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $354.94M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $205.9M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 44.9M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$19.14M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $328.05M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $241.15M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.70 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.70 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.61M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $30.75M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$31.51M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$35.36M |